A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
ALLTogether1 - A Treatment Study Protocol of the ALLTogether Consortium for Children and Young Adults (0-45 Years of Age) With Newly Diagnosed Acute Lymphoblastic Leukaemia (ALL)
Sponsor: Aamu Pediatric Cancer Foundation
Listed as NCT04307576, this PHASE3 trial focuses on Leukemia, Acute Lymphoblastic and remains actively recruiting participants. Sponsored by Aamu Pediatric Cancer Foundation, it has been updated 23 times since 2020, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
23 versions recorded-
Sep 2025 — Present [monthly]
Recruiting PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Recruiting PHASE3
-
Aug 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Jul 2024 — Aug 2024 [monthly]
Recruiting PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE3
▶ Show 18 earlier versions
-
Feb 2024 — Apr 2024 [monthly]
Recruiting PHASE3
-
Dec 2023 — Feb 2024 [monthly]
Recruiting PHASE3
-
Oct 2023 — Dec 2023 [monthly]
Recruiting PHASE3
-
Aug 2023 — Oct 2023 [monthly]
Recruiting PHASE3
-
Jun 2023 — Aug 2023 [monthly]
Recruiting PHASE3
-
Jan 2023 — Jun 2023 [monthly]
Recruiting PHASE3
-
Sep 2022 — Jan 2023 [monthly]
Recruiting PHASE3
-
Jun 2022 — Sep 2022 [monthly]
Recruiting PHASE3
-
Mar 2022 — Jun 2022 [monthly]
Recruiting PHASE3
-
Feb 2022 — Mar 2022 [monthly]
Recruiting PHASE3
-
Feb 2021 — Feb 2022 [monthly]
Recruiting PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Recruiting PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Nov 2020 — Dec 2020 [monthly]
Recruiting PHASE3
-
Oct 2020 — Nov 2020 [monthly]
Recruiting PHASE3
-
Sep 2020 — Oct 2020 [monthly]
Recruiting PHASE3
-
Jul 2020 — Sep 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Apr 2020 — Jul 2020 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Aamu Pediatric Cancer Foundation
- Acreditar - Associação de Pais e Amigos das Crianças com Cancro
- Amgen
- Assistance Publique - Hôpitaux de Paris
- Belgium Health Care Knowledge Centre
- Cancer Research UK
- Clinical Trial Center North (CTC North GmbH & Co. KG)
- Danish Cancer Society
- Danish Child Cancer Foundation
- Direction Générale de l'Offre de Soins
- Fundação Rui Osório de Castro
- German Society for Pediatric Oncology and Hematology GPOH gGmbH
- Grupo Português De Leucemias Pediátricas
- Karolinska Institutet
- Mats Heyman
- NordForsk
- Nova Laboratories Limited
- Pfizer
- Servier
- Swedish Cancer Society
- The Novo Nordic Foundation
- The Swedish Childhood Cancer Foundation
- The Swedish Research Council
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Aalborg, Denmark , Aarhus, Denmark , Aberdeen, United Kingdom , Amiens, France , Angers, France , Belfast, United Kingdom , Bergen, Norway , Besançon, France , Bielefeld, Germany , Birmingham, United Kingdom and 81 more locations